Pacira Biosciences, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Pacira Pharmaceuticals, Inc. (now Pacira Biosciences, Inc.) on September 26, 2011. The report discloses a specific corporate governance event regarding the departure of a senior executive.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to personnel changes and does not contain financial statements or performance data.
Material Changes
The material change reported is the resignation of Dr. William Lambert, Senior Vice President of Project and Alliance Management. His last day of employment was September 30, 2011. The Company stated that his duties and responsibilities will be absorbed by existing employees.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies beyond the executive departure.
Key Facts for Investor Verification
- Dr. William Lambert resigned as Sr. VP of Project and Alliance Management effective September 30, 2011.
- The Company plans to redistribute his responsibilities among current staff rather than immediately hiring a replacement.
- No financial impact or strategic shift was disclosed in this specific filing.